LTZ THERAPEUTICS
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
LTZ THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.ltztherapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
17 M USD
Investors List
Qiming Venture Partners
Qiming Venture Partners investment in Seed Round - LTZ Therapeutics
Tigermed
Tigermed investment in Seed Round - LTZ Therapeutics
K2 Global
K2 Global investment in Seed Round - LTZ Therapeutics
Official Site Inspections
http://www.ltztherapeutics.com Semrush global rank: 4.86 M Semrush visits lastest month: 1.82 K
- Host name: ec2-54-146-93-161.compute-1.amazonaws.com
- IP address: 54.146.93.161
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "LTZ Therapeutics"
LTZ Therapeutics
To maximize the drugability potential, we target approaches to improve clinical benefits based on reverse translational science and emerging biology of the tumor microenvironment. Identification of patients' unmet needs, novel targets, …See details»
About LTZ - LTZ Therapeutics
LTZ Therapeutics is an immunotherapy-focused global biotech company pursuing innovative therapies in oncology and autoimmune diseases. Pioneering a novel Myeloid Engager …See details»
LTZ Therapeutics - Crunchbase Company Profile
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need. LTZ Therapeutics raised over $20 million. View contacts for LTZ Therapeutics to access new leads and connect …See details»
LTZ Therapeutics - LinkedIn
LTZ Therapeutics is an immunotherapy-focused global biotech company pursuing innovative therapies in oncology and autoimmune diseases.See details»
LTZ Therapeutics Announces Over $20 Million Series A …
Jul 30, 2024 · REDWOOD CITY, Calif. & SHENZHEN, China – July 30, 2024 – LTZ Therapeutics, an immunotherapy-focused biotech company, today announced the completion of the company’s Series A financing of over $20 …See details»
LTZ Therapeutics: Contact Details, Revenue, Funding, Employees …
LTZ Therapeutics is a global biotech company focused on immunotherapy, developing innovative treatments for oncology and autoimmune diseases. Its pioneering myeloid engager platform …See details»
LTZ Therapeutics | LinkedIn
Innovating Immunotherapy for the Future | LTZ Therapeutics is an immunotherapy-focused global biotech company pursuing innovative therapies in oncology and autoimmune diseases.See details»
LTZ Announces over $10 Million Pre-A+ Financing to
May 31, 2023 · REDWOOD CITY, Calif. & SHENZHEN, China-- ( BUSINESS WIRE )-- LTZ Therapeutics – an immunotherapy-focused biotech company – today announced it has raised over $10 million in pre-A+ financing led...See details»
LTZ Therapeutics - VentureRadar
Develops innovative immunotherapies for cancer and other diseases with unmet clinical needs using reverse translational science, tumor biology, and machine learning.See details»
LTZ Therapeutics Announces Over $20 Million Series A Financing …
Jul 30, 2024 · REDWOOD CITY, Calif. & SHENZHEN, China, July 30, 2024--LTZ Therapeutics, an immunotherapy-focused biotech company, today announced the completion of the …See details»
Former Genentech execs launch new immunotherapy biotech LTZ ...
May 2, 2022 · After raising $17 million in seed funding, immunotherapy-focused biotech company, LTZ Therapeutics Inc., is announcing plans for the fledgling company whose acronym stands …See details»
LTZ Therapeutics Secures $17 Million Pre-Series A Financing for ...
Apr 7, 2022 · PALO ALTO, Calif. and SHENZHEN, China, April 7, 2022 /PRNewswire/ -- LTZ Therapeutics – an immunotherapy-focused biotech company, co-founded by seasoned drug …See details»
Team-LTZ Therapeutics
Stay ln Touch. General Inquiries. info@ltztherapeutics.com. Business Development. vivian.tian@ltztherapeutics.com; Locations. Redwood City, USA. 1100 Island Dr ...See details»
LTZ Therapeutics Secures $17 Million Pre-Series A Financing for ...
Apr 7, 2022 · LTZ Therapeutics announced it has raised $17 million in pre-Series A financing led by K2 Venture Partners, with participation from Qiming Venture Partners and Tigermed.See details»
LTZ Therapeutics - Overview, News & Similar companies - ZoomInfo
View LTZ Therapeutics (www.ltztherapeutics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
LTZ Announces over $10 Million Pre-A+ Financing to Advance
May 31, 2023 · LTZ Therapeutics – an immunotherapy-focused biotech company – today announced it has raised over $10 million in pre-A+ financing led by Qiming Venture Partners, …See details»
LTZ Therapeutics - Craft
LTZ Therapeutics has 5 employees across 2 locations. See insights on LTZ Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Pipeline-LTZ Therapeutics
LTZ's Myeloid Engager Platform activates innate receptors on myeloid cells following engagement with target-associated antigens (TAA) on target cells, leading to phagocytosis and potent …See details»
Myeloid Engager Pipeline - LTZ Therapeutics
Stay ln Touch. General Inquiries. info@ltztherapeutics.com. Business Development. vivian.tian@ltztherapeutics.com; Locations. Redwood City, USA. 1100 Island Dr ...See details»
In The News - LTZ Therapeutics
July 2024 LTZ Therapeutics Announces Over $20 Million Series A Financing for Development of its Myeloid Engager-Based Immunotherapy Pipeline. REDWOOD CITY, Calif. & SHENZHEN, …See details»